Fast Five Quiz: What to Know About Early-Stage Breast Cancer

Authors and Disclosures

Author(s)

Maurie Markman, MD

Clinical Professor of Medicine, Drexel University College of Medicine; President, Medicine & Science, Cancer Treatment Centers of America, Philadelphia, Pennsylvania

Disclosure: Maurie Markman, MD, has disclosed the following relevant financial relationships:
Received income in an amount equal to or greater than $250 from: Genentech, Inc; AstraZeneca Pharmaceuticals LP; Celgene; Clovis; Amgen

Pavani Chalasani, MD, MPH

Assistant Professor of Medicine, Section of Hematology/Oncology, Department of Medicine, Arizona Health Sciences Center, University of Arizona College of Medicine, Tucson, Arizona

Disclosure: Pavani Chalasani, MD, MPH, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Bayer, Heron Therapeutics
Received research grant from: Pfizer

Stefania Morganti, MD

Research Fellow, Dana-Farber Cancer Institute, Boston, Massachusetts

Disclosure: Stefania Morganti, MD, has disclosed no relevant financial relationships.

Giuseppe Curigliano, MD, PhD

Professor, Department of Oncology and Hemato-Oncology, University of Milano; Director Division of Early Drug Development, European Institute of Oncology, IRCCS, Milan, Italy

Disclosure: Giuseppe Curigliano, MD, PhD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for:Roche; Astra Zeneca; Daichii Sankyo; Lilly; Novartis; Menarini; Pfizer; Gilead; Exact Sciences; Merck
Serve(d) as a speaker or a member of a speakers bureau for: Lilly; Astra Zeneca; Daichii Sankyo; merck
Received research grant from: Merck